2022 Q4 Form 10-K Financial Statement

#000121390023025539 Filed on March 31, 2023

View on sec.gov

Income Statement

Concept 2022 Q4 2022 2021
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $4.510M $3.610M
YoY Change 24.93%
% of Gross Profit
Research & Development $320.0K $510.0K
YoY Change -37.25%
% of Gross Profit
Depreciation & Amortization $0.00 $10.00K $20.00K
YoY Change -50.0%
% of Gross Profit
Operating Expenses $1.310M $5.720M $456.8K
YoY Change 241.93% 1152.27% 9597.88%
Operating Profit -$5.715M -$456.8K
YoY Change 1151.2%
Interest Expense $1.470M $2.450M -$17.82K
YoY Change -7910.84% -13848.6%
% of Operating Profit
Other Income/Expense, Net $2.449M -$17.82K
YoY Change -13840.24%
Pretax Income $170.0K -$3.267M -$474.6K
YoY Change -142.29% 588.28% 9976.22%
Income Tax $300.0K $431.6K
% Of Pretax Income 176.47%
Net Earnings -$130.0K -$3.698M -$474.6K
YoY Change -67.66% 679.23% 9976.22%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$0.01 -$0.17 -$21.82K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q4 2022 2021
SHORT-TERM ASSETS
Cash & Short-Term Investments $177.9M $100.0K $505.5K
YoY Change 35095.16% -80.22% 4446.04%
Cash & Equivalents $128.0K $460.0K $90.00K
Short-Term Investments $177.8M
Other Short-Term Assets $0.00 $0.00 $223.1K
YoY Change -100.0% -100.0%
Inventory
Prepaid Expenses $6.667K
Receivables
Other Receivables
Total Short-Term Assets $134.6K $100.0K $728.7K
YoY Change -81.52% -86.28% 6452.7%
LONG-TERM ASSETS
Property, Plant & Equipment $7.414K $330.0K $320.0K
YoY Change 3.13%
Goodwill
YoY Change
Intangibles $1.925M
YoY Change
Long-Term Investments $177.8M $177.8M $174.2M
YoY Change 2.05% 2.05%
Other Assets $1.925M $500.0K $0.00
YoY Change -100.0%
Total Long-Term Assets $178.3M $178.3M $174.2M
YoY Change 2.34% 2.34% 92847.28%
TOTAL ASSETS
Total Short-Term Assets $134.6K $100.0K $728.7K
Total Long-Term Assets $178.3M $178.3M $174.2M
Total Assets $178.4M $178.4M $175.0M
YoY Change 1.99% 1.97% 88009.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.857M $5.000M $60.00K
YoY Change 8233.33%
Accrued Expenses $762.1K $0.00 $241.6K
YoY Change 215.47% -100.0% 168.57%
Deferred Revenue
YoY Change
Short-Term Debt $2.000M $2.000M $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.418M $7.400M $241.6K
YoY Change 2970.78% 2963.17% 35.5%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $4.300M $4.300M $6.038M
YoY Change -28.78% -28.78%
Total Long-Term Liabilities $1.384M $4.300M $6.038M
YoY Change -77.07% -28.78%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.418M $7.400M $241.6K
Total Long-Term Liabilities $1.384M $4.300M $6.038M
Total Liabilities $11.73M $11.70M $6.279M
YoY Change 86.82% 86.33% 3421.84%
SHAREHOLDERS EQUITY
Retained Earnings -$10.87M
YoY Change 96.05%
Common Stock $368.00
YoY Change 1836.84%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$10.87M $166.7M $168.7M
YoY Change
Total Liabilities & Shareholders Equity $178.4M $178.4M $175.0M
YoY Change 1.99% 1.97% 88009.15%

Cashflow Statement

Concept 2022 Q4 2022 2021
OPERATING ACTIVITIES
Net Income -$130.0K -$3.698M -$474.6K
YoY Change -67.66% 679.23% 9976.22%
Depreciation, Depletion And Amortization $0.00 $10.00K $20.00K
YoY Change -50.0%
Cash From Operating Activities -$260.0K -$1.223M -$528.3K
YoY Change 209.19% 131.42% 23804.07%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$1.440M -$1.110M -$174.2M
YoY Change -99.36%
Cash From Investing Activities -$1.440M -$1.105M -$174.2M
YoY Change -99.37%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.820M $1.950M 175.2M
YoY Change 3540.0% -98.89% 1314586.27%
NET CHANGE
Cash From Operating Activities -260.0K -$1.223M -528.3K
Cash From Investing Activities -1.440M -$1.105M -174.2M
Cash From Financing Activities 1.820M $1.950M 175.2M
Net Change In Cash 120.0K -$377.6K 494.4K
YoY Change -452.01% -176.37% 4346.04%
FREE CASH FLOW
Cash From Operating Activities -$260.0K -$1.223M -$528.3K
Capital Expenditures $0.00 $0.00 $0.00
Free Cash Flow -$260.0K -$1.223M -$528.3K
YoY Change 131.42%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-40743
CY2022 dei Entity Registrant Name
EntityRegistrantName
Verde Clean Fuels, Inc.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-1863331
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
600 Travis Street
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 5050
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Houston
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77002
CY2022 dei City Area Code
CityAreaCode
(469)
CY2022 dei Local Phone Number
LocalPhoneNumber
398-2200
CY2022 dei Security12b Title
Security12bTitle
Class A Common Stock, par value $0.0001 per share
CY2022 dei Trading Symbol
TradingSymbol
VGAS
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
175600000 usd
CY2022 dei Auditor Name
AuditorName
Marcum LLP
CY2022 dei Auditor Firm
AuditorFirmId
688
CY2022 dei Auditor Location
AuditorLocation
Houston, TX
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
127965 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
505518 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
6667 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
223144 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
134632 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
728662 usd
CY2022Q4 us-gaap Deferred Costs
DeferredCosts
511760 usd
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
177790585 usd
CY2021Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
174229680 usd
CY2022Q4 us-gaap Assets
Assets
178436977 usd
CY2021Q4 us-gaap Assets
Assets
174958342 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
5029363 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
241579 usd
CY2022Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
1950000 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
7363 usd
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
312446 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
119186 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7418358 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
241579 usd
CY2022Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
4312500 usd
CY2021Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
6037500 usd
CY2022Q4 us-gaap Liabilities
Liabilities
11730858 usd
CY2021Q4 us-gaap Liabilities
Liabilities
6279079 usd
CY2022Q4 cenqu Common Stock Subject To Possible Redemption Value
CommonStockSubjectToPossibleRedemptionValue
177578871 usd
CY2021Q4 cenqu Common Stock Subject To Possible Redemption Value
CommonStockSubjectToPossibleRedemptionValue
174225000 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
368 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
19 usd
CY2022Q4 cenqu Common Stock Value1
CommonStockValue1
82 usd
CY2021Q4 cenqu Common Stock Value1
CommonStockValue1
431 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10873202 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5546187 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-10872752 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-5545737 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
178436977 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
174958342 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5715022 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
456765 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-5715022 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-456765 usd
CY2022 us-gaap Interest Income Securities Other Us Government
InterestIncomeSecuritiesOtherUSGovernment
2455873 usd
CY2021 us-gaap Interest Income Securities Other Us Government
InterestIncomeSecuritiesOtherUSGovernment
4680 usd
CY2022 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
7363 usd
CY2021 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-22500 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2448510 usd
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-17820 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3266512 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-474585 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
431632 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-3698144 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-474585 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
20287 usd
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1442100 usd
CY2021 cenqu Excess Of Fair Values Of Anchor Shares
ExcessOfFairValuesOfAnchorShares
6265215 usd
CY2021 cenqu Sale Of Representative Shares
SaleOfRepresentativeShares
11627801 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
6366396 usd
CY2021 cenqu Unrealized Loss On Fair Value Changes Of Overallotment Option Liability
UnrealizedLossOnFairValueChangesOfOverallotmentOptionLiability
180000 usd
CY2021 cenqu Measurement Adjustment Of Class A Common Stocks Subject To Possible Redemption
MeasurementAdjustmentOfClassACommonStocksSubjectToPossibleRedemption
-30972951 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-474585 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-5545737 usd
CY2022 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
1725000 usd
CY2022 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
-3353871 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-3698144 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-10872752 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-3698144 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-474585 usd
CY2022 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
2455873 usd
CY2021 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
4680 usd
CY2021 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-22500 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
119186 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-216477 usd
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
223144 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4276024 usd
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
151626 usd
CY2022 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
7363 usd
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
312446 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1222521 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-528283 usd
CY2022 cenqu Principal Deposited In Trust Account
PrincipalDepositedInTrustAccount
1725000 usd
CY2021 cenqu Principal Deposited In Trust Account
PrincipalDepositedInTrustAccount
174225000 usd
CY2022 us-gaap Proceeds From Decommissioning Fund
ProceedsFromDecommissioningFund
619968 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1105032 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-174225000 usd
CY2021 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
169050000 usd
CY2021 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
6675000 usd
CY2021 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
225000 usd
CY2021 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
329317 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1950000 usd
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
373002 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1950000 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
175247681 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-377553 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
494398 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
505518 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
11120 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
127965 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
505518 usd
CY2022 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
511760 usd
CY2022 cenqu Deferred Underwriting Commissions Charged To Additional Paid In Capital
DeferredUnderwritingCommissionsChargedToAdditionalPaidInCapital
-1725000 usd
CY2021 cenqu Deferred Underwriting Commissions Charged To Additional Paid In Capital
DeferredUnderwritingCommissionsChargedToAdditionalPaidInCapital
6037500 usd
CY2022 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
3353871 usd
CY2021 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
30972951 usd
CY2021 cenqu Reclassification Of Overallotment Option From Liability To Equity
ReclassificationOfOverallotmentOptionFromLiabilityToEquity
180000 usd
CY2022 cenqu Founder Shares Description
FounderSharesDescription
The Company estimated the aggregate fair value of these founder shares attributable to anchor investors to be $6,270,000, or $7.60 per share.
CY2022Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1
CY2021Q3 cenqu Additional Purchase Units
AdditionalPurchaseUnits
2250000 shares
CY2021Q3 cenqu Underwriters Exercised Price Per Share
UnderwritersExercisedPricePerShare
10
CY2022Q4 us-gaap Business Combination Acquired Receivables Fair Value
BusinessCombinationAcquiredReceivablesFairValue
6265215 usd
CY2022 cenqu Issued Representative Shares
IssuedRepresentativeShares
189750 shares
CY2022 cenqu Fair Value Amount
FairValueAmount
1442100 usd
CY2022Q4 cenqu Sponsor Deposited
SponsorDeposited
1725000 usd
CY2022Q4 cenqu Gross Proceeds Percentage
GrossProceedsPercentage
0.01 pure
CY2022Q4 cenqu Fair Market Value Percentage
FairMarketValuePercentage
0.80 pure
CY2022 cenqu Acquires Outstanding Voting Percentage
AcquiresOutstandingVotingPercentage
0.50 pure
CY2022Q4 cenqu Net Tangible Assets
NetTangibleAssets
5000001 usd
CY2022 cenqu Trust Account Funds Percentage
TrustAccountFundsPercentage
0.01 pure
CY2022Q4 us-gaap Deposits
Deposits
1725000 usd
CY2022Q4 cenqu Dissolution Expenses
DissolutionExpenses
100000 usd
CY2022 cenqu Public Per Shares
PublicPerShares
10.1
CY2022 cenqu Excise Tax
ExciseTax
0.01 pure
CY2022Q4 us-gaap Cash
Cash
127965 usd
CY2022Q4 cenqu Working Capitals
WorkingCapitals
7072012 usd
CY2022 cenqu Net Proceeds
NetProceeds
37329178 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.35pt 0pt 0"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.35pt 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.35pt 0pt 0; text-align: justify">The preparation of consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.35pt 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.35pt 0pt 0; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. The most significant estimates that affected the consolidated financial statements as of December 31, 2022 are the calculations of the fair values of the over-allotment option, fair values of the representative shares and the fair values of the anchor shares. Such estimates may be subject to change as more current information becomes available. Accordingly, the actual results could differ significantly from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.35pt 0pt 0; text-align: justify; text-indent: 16.2pt"> </p>
CY2022Q4 us-gaap Cash
Cash
127965 usd
CY2021Q4 us-gaap Cash
Cash
505518 usd
CY2022Q4 us-gaap Marketable Securities
MarketableSecurities
177790585 usd
CY2022Q4 us-gaap Deferred Costs And Other Assets
DeferredCostsAndOtherAssets
511760 usd
CY2022 cenqu Potential Common Shares
potentialCommonShares
19612500 shares
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.35pt 0pt 0; text-align: justify"><b><i>Concentration of Credit Risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.35pt 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.35pt 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. At December 31, 2022, the Company has not experienced losses on this account.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2022Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2022Q4 us-gaap Assets Held In Trust
AssetsHeldInTrust
177790585 usd
CY2021Q4 us-gaap Assets Held In Trust
AssetsHeldInTrust
174229680 usd
CY2021Q3 cenqu Overallotment Liability
OverallotmentLiability
157500 usd
CY2021Q3 cenqu Overallotment Option
OverallotmentOption
22500 usd
CY2021Q3 cenqu Overallotment Liability Into Equity
OverallotmentLiabilityIntoEquity
180000 usd
CY2022 cenqu Purchase Price
PurchasePrice
1500000 usd
CY2022 cenqu Proposed Public Offering Description
ProposedPublicOfferingDescription
Additionally, upon consummation of the IPO, the Sponsor sold 75,000 Founder Shares to each of the 11 Anchor Investors that purchased at least 9.9% of the units sold in the IPO, at their original purchase price of approximately $0.0058 per share. The aggregate fair value of these founder shares attributable to anchor investors is $6,270,000, or $7.60 per share. The Company allocated $6,265,215, the excess of the fair value over the gross proceeds from these Anchor Investors, among Class A common stock, Public Warrants and Private Placement Warrants. 
CY2022Q4 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
3487500 shares
CY2022 cenqu Exceeds Price Per Share
ExceedsPricePerShare
12
CY2021 us-gaap Long Term Debt Average Amount Outstanding
LongTermDebtAverageAmountOutstanding
0 usd
CY2022Q4 us-gaap Sponsor Fees
SponsorFees
1725000 usd
CY2022Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
1725000 usd
CY2021Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
0 usd
CY2022Q4 cenqu Promissory Note Related Party Description
PromissoryNoteRelatedPartyDescription
On November 15, 2022, the Company issued an unsecured promissory note (the “Sponsor Note”) allowing the Company to borrow up to $467,500 from the Sponsor. Amounts drawn under the Sponsor Note bear no interest and are due and payable upon the earlier to occur of (i) the date on which CENAQ’s initial business combination is consummated and (ii) the liquidation of the Company on or before February 16, 2023 or such later liquidation date as may be approved by the Company’s stockholders. On November 15, 2022, the Company requested and received $100,000 under the Sponsor Note. There was $100,000 and $0 outstanding under the Sponsor Note as of December 31, 2022 and 2021, respectively. Such amounts are included in Proceeds from note payable-related party on the Consolidated Balance Sheets. As further described in Note 6, in connection with the Closing, and based on the $158,797,476 of redemptions, CENAQ Sponsor was due $184,612 under the Extension Note. At closing, CENAQ Sponsor was also due $100,000 under the Sponsor Note and $125,000 under the Promissory Note. However, on February 15, 2023, in lieu of repayment of the Extension Note and repayment of the Sponsor Note and Promissory Note, CENAQ entered into a new promissory note with the Sponsor totaling $409,612 (“New Promissory Note”). The New Promissory Note, cancels and supersedes the Extension Note and the Sponsor Note. The New Promissory note is non-interest bearing and the entire principal balance of the New Promissory Note is payable on or before February 15, 2024. The New Promissory Note is payable at Verde Clean Fuel’s election in cash or in Class A Common Stock at a conversion price of $10.00 per share. 
CY2021Q4 us-gaap Other Commitment
OtherCommitment
1500000 usd
CY2022Q4 cenqu Working Capital Loan Available
WorkingCapitalLoanAvailable
1500000 usd
CY2022Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1
CY2022 cenqu Business Combination Description
BusinessCombinationDescription
However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up period, which occurs (i) in the case of the Founder Shares, on the earlier of (A) six months after the completion of the initial Business Combination or (B) subsequent to the initial Business Combination, (x) if the last sale price of our Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 75 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property and (ii) in the case of the Private Placement Warrants and the respective Class A common stock underlying such warrants, 30 days after the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
CY2022 cenqu Business Combination Terms
BusinessCombinationTerms
P5Y
CY2022Q3 cenqu Subscription Agreement Description
SubscriptionAgreementDescription
Arb Clean Fuels Management LLC (“Arb Clean Fuels”), an entity affiliated with a member of the Sponsor, has agreed to purchase 7,000,000 shares to be sold in the PIPE Financing for an aggregate commitment of $70,000,000; provided, that, to the extent funds in the Trust Account immediately prior to the consummation of the business combination, after giving effect to the Company stockholders’ redemption rights, exceed $17,420,000, each $10.00 increment of such excess funds shall reduce Arb Clean Fuels’ commitment by $10.00 up to a maximum reduction of $20,000,000. Additionally, an entity unaffiliated with the Sponsor has agreed to purchase 200,000 shares for an aggregate commitment of $2,000,000.
CY2022 cenqu Original Financing Shares
OriginalFinancingShares
8000000 shares
CY2022 cenqu Clean Fuels Shares
CleanFuelsShares
7000000 shares
CY2022 us-gaap Supplemental Deferred Purchase Price
SupplementalDeferredPurchasePrice
70000000 usd
CY2022 cenqu Redemption Rights Exceed
RedemptionRightsExceed
17420000 usd
CY2022 cenqu Price Per Shares
PricePerShares
10
CY2022 cenqu Excess Trust Account
ExcessTrustAccount
17420000 usd
CY2022Q4 cenqu Committed Shares
CommittedShares
2000000 shares
CY2022 cenqu Committed Purchase Prices
CommittedPurchasePrices
20000000 usd
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21752250 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21752250 shares
CY2022Q4 us-gaap Shares Outstanding
SharesOutstanding
17172959 shares
CY2022Q4 srt Financing Receivable Nonaccrual To Outstanding Percent
FinancingReceivableNonaccrualToOutstandingPercent
0.7895 pure
CY2022 cenqu Business Combination Agreement Description
BusinessCombinationAgreementDescription
The stockholders (a) approved and adopted the Business Combination Agreement and Plan of Reorganization, dated as of August 12, 2022 (the “Business Combination Agreement”), among CENAQ, Verde Clean Fuels OpCo, LLC, a Delaware limited liability company and a wholly owned subsidiary of CENAQ (“OpCo”), Bluescape Clean Fuels Holdings, LLC, a Delaware limited liability company (“Holdings”), Bluescape Clean Fuels Intermediate Holdings, LLC, a Delaware limited liability company (“Intermediate”), and CENAQ Sponsor LLC, pursuant to which (i) (A) CENAQ will contribute to OpCo (1) all of its assets (excluding its interests in OpCo and the aggregate amount of cash required to satisfy any exercise by CENAQ stockholders of their redemption rights (“Redemption Rights”) pursuant to CENAQ’s third amended and restated certificate of incorporation (the “Charter”)) and (2) 22,500,000 newly issued shares of Class C common stock, par value $0.0001 per share (the “Class C Common Stock”), of CENAQ (such shares, the “Holdings Class C Shares”) and (B) in exchange therefor, OpCo will issue to CENAQ a number of Class A common units of OpCo equal to the number of total shares of Class A common stock, par value $0.0001 per share (the “Class A Common Stock”), of CENAQ issued and outstanding immediately after the closing (the “Closing”) of the transactions (the “Transactions”) contemplated by the Business Combination Agreement (taking into account the private offering of securities of Verde Clean Fuels, Inc. to certain investors in connection with the business combination (the “PIPE Financing”) and following the exercise of Redemption Rights) (such transactions, the “SPAC Contribution”) and (ii) immediately following the SPAC Contribution, (A) Holdings will contribute to OpCo 100% of the issued and outstanding limited liability company interests of Intermediate and (B) in exchange therefor, OpCo will transfer to Holdings (1) 22,500,000 Class C common units (the “Class C OpCo Units”) of OpCo and the Holdings Class C Shares (such transactions, the “Holdings Contribution” and, together with the SPAC Contribution, the “business combination”) and (b) approved the business combination and the Transactions (the “Business Combination Proposal”).
CY2022 cenqu Stockholders Shares Description
StockholdersSharesDescription
The proposal to increase the number of authorized shares of CENAQ’s capital stock, par value $0.0001 per share, from 221,000,000 shares, consisting of (a) 220,000,000 shares of common stock, including 200,000,000 shares of Class A Common Stock and 20,000,000 shares of Class B common stock, par value $0.0001 per share, and (b) 1,000,000 shares of preferred stock, to 376,000,000 shares, consisting of (i) 350,000,000 shares of Class A Common Stock, (ii) 25,000,000 shares of Class C Common Stock and (iii) 1,000,000 shares of preferred stock, was approved.
CY2022 cenqu Restated Limited Liability
RestatedLimitedLiability
(a) the issuance of 22,500,000 shares of Class C Common Stock pursuant to the Business Combination Agreement, (b) the issuance of 22,500,000 shares of Class A Common Stock upon the exchange of the Class C OpCo Units, together with an equal number of shares of Class C Common Stock, for shares of Class A Common Stock pursuant to the amended and restated limited liability company agreement of OpCo and the Proposed Fourth A&R Charter and (c) the issuance and sale of 8,000,000 shares of Class A Common Stock in the PIPE Financing (the “Nasdaq Proposal”).
CY2022 us-gaap Business Combination Control Obtained Description
BusinessCombinationControlObtainedDescription
On February 15, 2023 (the “Closing Date”), as contemplated by the Business Combination Agreement:  ●CENAQ filed a Fourth Amended and Restated Certificate of Incorporation (the “Fourth A&R Charter”) with the Secretary of State of the State of Delaware, pursuant to which CENAQ changed its name to “Verde Clean Fuels, Inc.” and the number of authorized shares of Verde Clean Fuels’ capital stock, par value $0.0001 per share, was increased to 376,000,000 shares, consisting of (i) 350,000,000 shares of Class A common stock, par value $0.0001 per share (the “Class A Common Stock”), (ii) 25,000,000 shares of Class C common stock, par value $0.0001 per share (the “Class C Common Stock”), and (iii) 1,000,000 shares of preferred stock, par value $0.0001 per share;   ●(A) CENAQ contributed to OpCo (i) all of its assets (excluding its interests in OpCo and the aggregate amount of cash required to satisfy any exercise by CENAQ stockholders of their Redemption Rights (as defined below)) and (ii) 22,500,000 newly issued shares of Class C Common Stock (such shares, the “Holdings Class C Shares”) and (B) in exchange therefor, OpCo issued to CENAQ a number of Class A common units of OpCo (the “Class A OpCo Units”) equal to the number of total shares of Class A Common Stock issued and outstanding immediately after the closing (the “Closing”) of the transactions (the “Transactions”) contemplated by the Business Combination Agreement (taking into account the PIPE Investment (as defined below) and following the exercise by CENAQ stockholders of their Redemption Rights) (such transactions, the “SPAC Contribution”); and   ●Immediately following the SPAC Contribution, (A) Holdings contributed to OpCo 100% of the issued and outstanding limited liability company interests of Intermediate and (B) in exchange therefor, OpCo transferred to Holdings (i) 22,500,000 Class C common units of OpCo (the “Class C OpCo Units” and, together with the Class A OpCo Units, the “OpCo Units”) and (ii) the Holdings Class C Shares (such transactions, the “Holdings Contribution” and, together with the SPAC Contribution, the “Business Combination”).  
CY2022 us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
32000000 usd
CY2022Q4 us-gaap Shares Issued
SharesIssued
3200000 shares
CY2022 cenqu Redemption Rights Description
RedemptionRightsDescription
Holders of 15,403,880 Class A Common Stock sold in CENAQ’s initial public offering (the “public shares”) properly exercised their right to have their public shares redeemed (the “Redemption Rights”) for a pro rata portion of the trust account (the “Trust Account”) which holds the proceeds from CENAQ’s initial public offering, funds from CENAQ’s payment to extend the time to consummate a business combination and interest earned, calculated as of two business days prior to the Closing, which was approximately $10.31 per share, or $158,797,476 in the aggregate. The remaining balance in the Trust Account (after giving effect to the Redemption Rights) was $19,031,516. 
CY2022Q4 us-gaap Escrow Deposit
EscrowDeposit
1725000 usd
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
1725000 usd
CY2022Q4 us-gaap Escrow Deposit
EscrowDeposit
158797476 usd
CY2022Q4 us-gaap Due From Banks
DueFromBanks
184612 usd
CY2022Q4 us-gaap Due From Affiliates
DueFromAffiliates
100000 usd
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
125000 usd
CY2023Q1 cenqu Debt Instrument Convertible Conversion Price
DebtInstrumentConvertibleConversionPrice
10
CY2022 cenqu Other Additional Transaction Expense
OtherAdditionalTransactionExpense
The Company also obtained additional transaction expense reductions leading up to the Closing including a reduction to the deferred underwriting fees and a reduction to legal expenses. In connection with the execution of the Business Combination Agreement, on August 12, 2022, the Company, Intermediate and Holdings entered into a letter agreement with the underwriters, pursuant to which, among other things, (i) Imperial Capital, LLC agreed to forfeit all of its 1,423,125 Private Placement Warrants and all of its 156,543 Representative Shares, (ii) I-Bankers Securities, Inc. agreed to forfeit all of its 301,875 Private Placement Warrants and all of its 33,207 Representative Shares and (iii) the underwriters agreed to reduce their deferred underwriting fees related to the IPO from $6,037,500 to $4,312,500. As part of the Closing, the underwriters agreed to further reduce their deferred underwriting fees related to the IPO from $4,312,500 to $1,700,000. Additionally, as of December 31, 2022, the Company had $4,110,755 of accrued legal expenses related to the Closing (included in Accounts payable and accrued expenses) and $511,760 of legal expenses recorded to Deferred financing costs related to the PIPE capital raise. However, the Company’s legal counsel agreed to reduce total legal expenses to $3,250,000 in connection with the Closing. The underwriter’s counsel involved in the PIPE capital raise also agreed, in connection with Closing, to reduce total legal expenses included in deferred financing costs to $325,000. 
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q3 cenqu Founder Share
FounderShare
562500 shares
CY2022 cenqu Percentage Of Conversion Shares
PercentageOfConversionShares
0.20 pure
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
19612500 shares
CY2022 cenqu Public Warrants
PublicWarrants
12937500 shares
CY2022 cenqu Private Placement Warrants
PrivatePlacementWarrants
6675000 shares
CY2022 us-gaap Class Of Warrant Or Right Reason For Issuing To Nonemployees
ClassOfWarrantOrRightReasonForIssuingToNonemployees
We may call the warrants for redemption, in whole and not in part, at a price of $0.01 per warrant:    ● at any time after the warrants become exercisable;         ● upon not less than 30 days’ prior written notice of redemption to each warrant holder;         ● if, and only if, the reported last sale price of the shares of Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations), for any 20 trading days within a 30 trading day period commencing at any time after the warrants become exercisable and ending on the third business day prior to the notice of redemption to warrant holders; and         ● if, and only if, there is a current registration statement in effect with respect to the shares of Class A common stock underlying such warrants.  
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Restructuring Charges
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges
195311 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Restructuring Charges
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges
53826 usd
CY2022Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
119186 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
41721 usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
76125 usd
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
95547 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
195311 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
95547 usd
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
119186 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
312446 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
19422 usd
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-94557 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
99764 usd
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
94557 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
431632 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
0 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
198672 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
99764 usd
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
95547 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.0108 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Depletion
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepletion
-0.3117 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.0305 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.1992 pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.1322 pure
CY2021Q4 us-gaap Deferred Costs
DeferredCosts
usd
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
usd
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
usd
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
usd
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
usd
CY2021 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
usd
CY2022 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
usd
CY2022 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
usd
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
usd
CY2021 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
usd
CY2021 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
usd
CY2021 us-gaap Proceeds From Decommissioning Fund
ProceedsFromDecommissioningFund
usd
CY2022 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
usd
CY2022 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
usd
CY2022 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
CY2021 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
usd
CY2021 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
usd
CY2022 cenqu Reclassification Of Overallotment Option From Liability To Equity
ReclassificationOfOverallotmentOptionFromLiabilityToEquity
usd
CY2021Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
usd
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
usd
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
usd
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
usd
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001841425

Files In Submission

Name View Source Status
0001213900-23-025539-index-headers.html Edgar Link pending
0001213900-23-025539-index.html Edgar Link pending
0001213900-23-025539.txt Edgar Link pending
0001213900-23-025539-xbrl.zip Edgar Link pending
cenqu-20221231.xsd Edgar Link pending
ex10-13_001.jpg Edgar Link pending
ex10-14_001.jpg Edgar Link pending
ex10-14_002.jpg Edgar Link pending
ex10-15_001.jpg Edgar Link pending
ex10-16_001.jpg Edgar Link pending
ex10-17_001.jpg Edgar Link pending
ex10-18_001.jpg Edgar Link pending
f10k2022ex10-13_verdeclean.htm Edgar Link pending
f10k2022ex10-14_verdeclean.htm Edgar Link pending
f10k2022ex10-15_verdeclean.htm Edgar Link pending
f10k2022ex10-16_verdeclean.htm Edgar Link pending
f10k2022ex10-17_verdeclean.htm Edgar Link pending
f10k2022ex10-18_verdeclean.htm Edgar Link pending
f10k2022ex10-19_verdeclean.htm Edgar Link pending
cenqu-20221231_cal.xml Edgar Link unprocessable
cenqu-20221231_def.xml Edgar Link unprocessable
cenqu-20221231_lab.xml Edgar Link unprocessable
cenqu-20221231_pre.xml Edgar Link unprocessable
f10k2022ex10-20_verdeclean.htm Edgar Link pending
f10k2022ex31-1_verdeclean.htm Edgar Link pending
f10k2022ex32-1_verdeclean.htm Edgar Link pending
f10k2022ex4-5_verdeclean.htm Edgar Link pending
f10k2022_verdeclean.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
f10k2022_verdeclean_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable